Brighton Jones’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Brighton Jones's MYGN Position: Q3 2026 in Review
Brighton Jones sold out of Myriad Genetics (MYGN) in Q3 2026, closing a stake of 18,760 shares — an estimated $107K sold.
Brighton Jones first reported a position in MYGN in Q2 2026 and held it in 1 quarter. The position peaked at $107K in Q2 2026. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Brighton Jones reported no remaining Myriad Genetics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 18,760 Myriad Genetics shares in Q3 2026, an estimated $107K.
- Brighton Jones first reported a position in Myriad Genetics in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Myriad Genetics position peaked at $107K in Q2 2026.
- 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.